Quillivant Suspension, Extended Release
Pricing Report NDC 24478-324-06

Current NADAC: $1.80315 per ML · Effective Aug 19, 2026

Current Package Pricing Information

The current wholesale acquisition cost for Quillivant Xr (NDC 24478-324-06) is $1.80315 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human prescription drug provided by Nextwave Pharmaceuticals, Inc, this medication is distributed in a 1 BOTTLE in 1 CARTON / 180 mL in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.80315
Per ML

Effective Date
Aug 19, 2026
Data Status
As of Sep 09, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE in 1 CARTON / 180 mL in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2018, the NADAC wholesale price for (NDC ) has moved within a range of $1.45757 to $1.81054 per ML. Over this 7 years and 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.4576 - $1.8105
Market Volatility
24.22% Variance
Latest Trend
0.04%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $1.80315 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jul 22, 2026 $1.80386 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jun 17, 2026 $1.80457 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
May 20, 2026 $1.80502 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Apr 22, 2026 $1.80269 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Mar 18, 2026 $1.80242 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Feb 18, 2026 $1.80651 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jan 21, 2026 $1.80634 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Dec 17, 2025 $1.80626 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Nov 19, 2025 $1.80228 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Oct 22, 2025 $1.80232 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Sep 17, 2025 $1.80553 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026